Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 2
2004 1
2006 1
2008 4
2009 3
2010 8
2011 3
2012 6
2013 2
2014 1
2015 1
2021 1
2022 1
2023 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

33 results

Results by year

Filters applied: . Clear all
Page 1
Ryanodine receptor channelopathies.
Betzenhauser MJ, Marks AR. Betzenhauser MJ, et al. Pflugers Arch. 2010 Jul;460(2):467-80. doi: 10.1007/s00424-010-0794-4. Epub 2010 Feb 24. Pflugers Arch. 2010. PMID: 20179962 Free PMC article. Review.
Calcium Channel Mutations in Cardiac Arrhythmia Syndromes.
Betzenhauser MJ, Pitt GS, Antzelevitch C. Betzenhauser MJ, et al. Curr Mol Pharmacol. 2015;8(2):133-42. doi: 10.2174/1874467208666150518114857. Curr Mol Pharmacol. 2015. PMID: 25981977 Free PMC article. Review.
PERK Inhibition by HC-5404 Sensitizes Renal Cell Carcinoma Tumor Models to Antiangiogenic Tyrosine Kinase Inhibitors.
Stokes ME, Calvo V, Fujisawa S, Dudgeon C, Huang S, Ballal N, Shen L, Gasparek J, Betzenhauser M, Taylor SJ, Staschke KA, Rigby AC, Mulvihill MJ, Bose N, Lightcap ES, Surguladze D. Stokes ME, et al. Among authors: betzenhauser m. Clin Cancer Res. 2023 Dec 1;29(23):4870-4882. doi: 10.1158/1078-0432.CCR-23-1182. Clin Cancer Res. 2023. PMID: 37733811 Free PMC article.
Ryanodine receptor studies using genetically engineered mice.
Kushnir A, Betzenhauser MJ, Marks AR. Kushnir A, et al. Among authors: betzenhauser mj. FEBS Lett. 2010 May 17;584(10):1956-65. doi: 10.1016/j.febslet.2010.03.005. Epub 2010 Mar 7. FEBS Lett. 2010. PMID: 20214899 Free PMC article. Review.
Discovery of 2-amino-3-amido-5-aryl-pyridines as highly potent, orally bioavailable, and efficacious PERK kinase inhibitors.
Calvo V, Surguladze D, Li AH, Surman MD, Malibhatla S, Bandaru M, Jonnalagadda SK, Adarasandi R, Velmala M, Singireddi DRP, Velpuri M, Nareddy BR, Sastry V, Mandati C, Guguloth R, Siddiqui S, Patil BS, Chad E, Wolfley J, Gasparek J, Feldman K, Betzenhauser M, Wiens B, Koszelak-Rosenblum M, Zhu G, Du H, Rigby AC, Mulvihill MJ. Calvo V, et al. Among authors: betzenhauser m. Bioorg Med Chem Lett. 2021 Jul 1;43:128058. doi: 10.1016/j.bmcl.2021.128058. Epub 2021 Apr 23. Bioorg Med Chem Lett. 2021. PMID: 33895276 Free article.
33 results